The Food and Drug Administration has warned Novo Nordisk that a television advertisement promoting its newly launched Wegovy pill for obesity contains “false or misleading” claims, saying the spot misbrands the drug and violates federal law, CNBC reported Monday.
FDA: Novo Nordisk’s Obesity Pill Ad Is Misleading
Related articles
You may also be interested in
Exorcists at Vatican Urge Pope to Expand Training Worldwide
Marzo 25, 2026
The International Association of Exorcists met with Pope Leo XIV at the Vatican on March 13, expressing concern about the growing prevalence of occultism, esotericism,
